Clinical Ink
Clinical Ink is a clinical technology company that provides electronic clinical outcome assessment (eCOA), eSource, and decentralized clinical trial solutions to pharmaceutical, biotech, and contract research organizations. Its platform captures patient- and site-reported data electronically at the point of care or remotely, aiming to improve data quality, reduce trial timelines, and support hybrid and virtual study designs. The company generates revenue through software licensing, technology-enabled services, and implementation and support fees for clinical trials globally.
- Electronic Health Records
- Clinical Trial & Research Software
- Revenue
- $90.0M
- Employees
- 450
- Founded
- 2007
- Headquarters
- Berwyn, United States of America
What 25 Arbolus experts think of Clinical Ink
NPS scores for Clinical Ink reflect a predominance of positive sentiment (scores 7-10 comprise the majority), particularly among large pharma and operations executives. Renewal intent is generally high among key spenders and influencers, with only small pockets of uncertainty among user roles. Most customers are well into full implementation or piloting, signaling strong product stickiness. Common praise centers around project kickoff, integration benefits, user interface simplicity, and site/staff satisfaction. Weaknesses, where cited, focus on feature breadth and complex protocol handling. Overall Customer Sentiment: Positive
Who reviewed Clinical Ink
- C-Suite 60% (15)
- Director 36% (9)
- Manager 4% (1)
Employer names and spend open in the full report, along with the other 22 customers.
Everything 25 customers told us about Clinical Ink.
Employer names, spend, renewal intent and every written answer behind the numbers on this page.
Sentiment
0 Net Promoter Score, from 25 scored reviews- Promoters 6
- Passives 13
- Detractors 6
Cumulative NPS by month
+0 over 6 months- Mar 7
- Apr 7
- May 7
- Jun 7
- Jul 7
- Sep 7
Net Promoter Score across 7 reviews, accumulated up to each month. Category median 26 across 7 companies.
Praised
- Modular Expansion & Deeper Integration
- Platform Consolidation Trend
- Faster Data Delivery and Quality
- Responsive Project Management
Criticised
- Platform Unification and Agility
- Switching Driven by Integration Needs
- Competitive Feature Breadth
- Analytics and Data Integration Gaps
What customers say
Renewal intent
Plan to renew 60%Plan to renew, by seniority
- 40% 10 answers
- 100% 4 answers
- 100% 1 answer
- 8.7/10 Average score from customers who will renew
- 6.8/10 Average score from undecided customers
- 5/10 Average score from customers not renewing
Top alternatives
Most weighed by Clinical Ink customers
Report
More in Data & Analytics
Other companies in Data & Analytics with a customer report.
For people who use Clinical Ink
Do you use Clinical Ink at work?
Share your software review and get matched to paid projects. Arbolus pays you every time a client reads your review.
- 25 customers of Clinical Ink have already contributed
Takes a few minutes. Your identity stays anonymous.